GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
T

Tecan Group TECN.SW · CHF

Health Care · SIX · 🇨🇭 Switzerland

Compare

258.20

+0.23%

Close of 9 Nov 2026, in CHF

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Tecan Group

Its shares trade on SIX under the ticker TECN.SW. It has been listed since 4 May 2001. In the fiscal year to 31 December 2025, it reported revenue of CHF 882.5m and a net loss of CHF 110.7m. At that date it held total assets of CHF 1.70bn and shareholders' equity of CHF 1.15bn.

Tecan Group AG is a holding company, which engages in the development, production, and distribution of laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics. The company is headquartered in Maennedorf, Zuerich. The company went IPO on 2001-05-04. Its product portfolio is diversified into several product groups. The Liquid Handling & Robotics group encompasses laboratory technologies for safety, among others. The Reader & Washer product group covers micro plate instruments. The Microarray Products group includes microarray scanner and automated hybridization station. The HP D300 Digital Dispenser and Sample Management product groups cover systems for automated management of sample libraries. The Components group covers the supply services of products for laboratory automation instruments. The OEM (original equipment manufacturing) product group covers platform-based systems, systems from scratch and Cavro OEM Components. The firm also offers packaged software and consumables through Software and Consumables product groups, respectively.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Life Sciences Tools & Services
Listed since
4 May 2001
Employees
1,932
Website
tecan.com ↗

Leadership

Pay as last reported

  • Dr. Lukas BraunschweilerNon-Executive Chairman of the BoardCHF 552,000
  • Dr. Achim Von LeoprechtingChief Executive Officer, Member of the Management BoardCHF 3.0m
  • Ms. Monica ManotasChief Executive Officer, Director, since 2024CHF 66,000
  • Ms. Tania MickiChief Financial Officer, Member of the Management BoardCHF 1.6m
  • Ms. Ingrid PurgstallerChief People Officer, Member of the Management Board
  • Dr. Wael YaredExecutive Vice President, Chief Technology Officer, Head Research and Development, Member of the Management Board
  • Mr. Andreas WilhelmExecutive Vice President, General Counsel and Secretary of the Board of Directors, Member of the Management Board
  • Ms. Mukta AcharyaExecutive Vice President, Head of the Life Sciences Business Division, Member of the Management Board
  • Mr. Ralf GriebelExecutive Vice President, Head of the Partnering Business division, Member of the Management Board
  • Mr. Ulrich KanterExecutive Vice President, Global Head of Operations & IT, Member of the Management Board
  • Mr. Erik NorstromExecutive Vice President, Head of Corporate Development, Member of the Management Board
  • Mr. Matthias GillnerNon-Executive DirectorCHF 272,000

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
85
Environment
70
Social
93
Governance
91
Direct emissions (scope 1)
2,010 t
Energy emissions (scope 2)
7,908 t
Value chain emissions (scope 3)
439,268 t
Women in the workforce
43.67%
Carbon reduction policy
No
Human rights policy
Yes

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Tecan Group AG holds several key strengths that contribute to its success in the market.

Weaknesses

  • Despite its strengths, Tecan Group AG faces certain weaknesses that pose challenges to its growth.

Opportunities

  • Tecan Group AG can leverage the following opportunities to drive future growth and expansion.

Threats

  • Tecan Group AG also faces certain threats that may hinder its growth and profitability prospects.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.